Clinical trials
Active, not recruiting Phase 3 Fallopian Tube Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| AbbVie | 1 |
| CanariaBio Inc. | 1 |
| Corcept Therapeutics | 1 |
| Genmab | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| NRG Oncology | 1 |
| Shanghai Gynecologic Oncology Group | 1 |
| pharmaand GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 13 |
| Ovarian Neoplasms | 9 |
| Carcinoma, Ovarian Epithelial | 4 |
| Brenner Tumor | 2 |
| Neoplasms | 2 |
| Peritoneal Neoplasms | 2 |
| Adenocarcinoma, Clear Cell | 1 |
| Adenocarcinoma, Mucinous | 1 |
| Carcinoma | 1 |
| Pathologic Complete Response | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.